多中心临床试验多中心临床试验

Same author

[Overtreatment in intensive care medicine].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2019

Same author

Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan.

Clinical pharmacology and therapeutics·2016

Same author

Regulatory review: How do agencies ensure the quality of decision making?

Clinical pharmacology and therapeutics·2013

Same author

Gatekeepers and enablers: how drug regulators respond to a challenging and changing environment by moving toward a proactive attitude.

Clinical pharmacology and therapeutics·2013

Same author

Expediting patients' access to medicines by improving the predictability of drug development and the regulatory approval process.

Clinical pharmacology and therapeutics·2009

Same author

How can we provide effective training for research ethics committee members? A European assessment.

Journal of medical ethics·2008

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

多中心临床试验多中心临床试验

相关概念视频

[Overtreatment in intensive care medicine].

Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan.

Regulatory review: How do agencies ensure the quality of decision making?

Gatekeepers and enablers: how drug regulators respond to a challenging and changing environment by moving toward a proactive attitude.

Expediting patients' access to medicines by improving the predictability of drug development and the regulatory approval process.

How can we provide effective training for research ethics committee members? A European assessment.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

多中心临床试验多中心临床试验

相关概念视频

相关文章

[Overtreatment in intensive care medicine].

Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan.

Regulatory review: How do agencies ensure the quality of decision making?

Gatekeepers and enablers: how drug regulators respond to a challenging and changing environment by moving toward a proactive attitude.

Expediting patients' access to medicines by improving the predictability of drug development and the regulatory approval process.

How can we provide effective training for research ethics committee members? A European assessment.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.